Display options
Cite
Warnock DW, Arthington-Skaggs BA, Li RK. Antifungal drug susceptibility testing and resistance in Aspergillus. Drug Resist Updat. 1999;2(5):326-334doi: 10.1054/drup.1999.0092.
Warnock, D. W., Arthington-Skaggs, B. A., & Li, R. K. (1999). Antifungal drug susceptibility testing and resistance in Aspergillus. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2(5), 326-334. https://doi.org/10.1054/drup.1999.0092
Warnock, David W., et al. "Antifungal drug susceptibility testing and resistance in Aspergillus." Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 2,5 (1999): 326-334. doi: https://doi.org/10.1054/drup.1999.0092
Warnock DW, Arthington-Skaggs BA, Li RK. Antifungal drug susceptibility testing and resistance in Aspergillus. Drug Resist Updat. 1999 Oct;2(5):326-334. doi: 10.1054/drup.1999.0092. PMID: 11504507.
Copy Download .nbib Format: NLM
Share it on

Drug Resist Updat. 1999 Oct;2(5):326-334. doi: 10.1054/drup.1999.0092.

Antifungal drug susceptibility testing and resistance in Aspergillus.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

David W. Warnock, Beth A. Arthington-Skaggs, Ren-Kai Li

Affiliations

  1. Mycotic Diseases Branch, Centers for Disease Control Prevention, Atlanta, USA

PMID: 11504507 DOI: 10.1054/drup.1999.0092

Abstract

Aspergillus species are the most common causes of invasive mold infections in immunocompromised patients. The introduction of new antifungal agents, and recent reports of resistance emerging during treatment of aspergillus infections, have highlighted the need for standardized methods of antifungal drug susceptibility testing for filamentous fungi. This review describes the methods that are now being developed for the in vitro testing of Aspergillus species, and the results of attempts to correlate in vitro findings with in vivo outcome. The mechanisms and clinical importance of resistance to the different agents used in the treatment of human aspergillosis are discussed. Copyright 1999 Harcourt Publishers Ltd.

Publication Types